Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Is there hope from molecular therapies?

Date

02 Dec 2023

Session

Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Topics

Targeted Therapy

Tumour Site

Gynaecological Malignancies; Sarcoma

Presenters

Clare Scott

Authors

C.L. Scott

Author affiliations

Cancer Biology And Stem Cells, Walter and Eliza Hall Institute WEHI, 3052 - Parkville/AU

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

02 Dec 2023

A case of early stage LMS that will recur as a single lesion 7 months later

Presenter: Smruti Koppikar

Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Resources:

Slides

Webcast

02 Dec 2023

Defining the role of chemotherapy: When and which

Presenter: Smruti Koppikar

Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Resources:

Slides

Webcast

02 Dec 2023

Should all patients receive radiotherapy?

Presenter: Aisha Miah

Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Resources:

Slides

Webcast

02 Dec 2023

Q&A and discussion

Presenter: All Speakers

Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)

Resources:

Webcast